Literature DB >> 17716313

Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women.

Jeffrey B Payne1, Julie A Stoner, Pirkka V Nummikoski, Richard A Reinhardt, Arthur D Goren, Mark S Wolff, Hsi-Ming Lee, James C Lynch, Robert Valente, Lorne M Golub.   

Abstract

AIM: Determine the efficacy of 2-year continuous subantimicrobial dose doxycycline (SDD; 20 mg bid) on alveolar bone in post-menopausal osteopenic, oestrogen-deficient women undergoing periodontal maintenance in a 2-year double-blind, placebo-controlled, randomized clinical trial.
MATERIAL AND METHODS: One-hundred and twenty-eight subjects randomized to SDD or placebo (n=64 each). Posterior vertical bite wings taken at baseline, 1 and 2 years for alveolar bone density (ABD), using radiographic absorptiometry (RA) and computer-assisted densitometric image analysis (CADIA), and alveolar bone height (ABH). Statistical analyses utilized generalized estimating equations; primary analyses were intent to treat (ITT). Results are presented as SDD versus placebo.
RESULTS: Under ITT, there was no statistically significant effect of SDD on ABD loss (RA: p=0.8; CADIA: p=0.2) or ABH loss (p=0.2). Most sites (81-95%) were inactive. For subgroup analyses, mean CADIA was higher with SDD for non-smokers (p=0.05) and baseline probing depths > or =5 mm (p=0.003). SDD was associated with 29% lower odds of more progressive ABH loss in women >5 years post-menopausal (p=0.05) and 36% lower among protocol-adherent subjects (p=0.03).
CONCLUSIONS: In post-menopausal osteopenic women with periodontitis, SDD did not differ overall from placebo. Based on exploratory subgroup analyses, additional research is needed to determine the usefulness of SDD in non-smokers, subjects >5 years post-menopausal and in deeper pockets. Protocol registered at (ClinicalTrials.gov). Identifier: NCT00066027.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716313      PMCID: PMC2174266          DOI: 10.1111/j.1600-051X.2007.01115.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  40 in total

1.  Radiographic absorptiometry method in measurement of localized alveolar bone density changes.

Authors:  E D Kuhl; P V Nummikoski
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2000-03

2.  Alveolar bone height and postcranial bone mineral density: negative effects of cigarette smoking and parity.

Authors:  C F Hildebolt; T K Pilgram; N Yokoyama-Crothers; M W Vannier; M Dotson; J Muckerman; J Hauser; S Cohen; E E Kardaris; P Hanes; M K Shrout; R Civitelli
Journal:  J Periodontol       Date:  2000-05       Impact factor: 6.993

3.  Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects.

Authors:  J G Caton; S G Ciancio; T M Blieden; M Bradshaw; R J Crout; A F Hefti; J M Massaro; A M Polson; J Thomas; C Walker
Journal:  J Clin Periodontol       Date:  2001-08       Impact factor: 8.728

4.  Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.

Authors:  Roberto Civitelli; Thomas K Pilgram; Mary Dotson; Jane Muckerman; Nancy Lewandowski; Reina Armamento-Villareal; Naoko Yokoyama-Crothers; E Eugenia Kardaris; Jay Hauser; Sheldon Cohen; Charles F Hildebolt
Journal:  Arch Intern Med       Date:  2002-06-24

5.  Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne.

Authors:  Robert Skidmore; Rodney Kovach; Clay Walker; John Thomas; Mark Bradshaw; James Leyden; Christopher Powala; Robert Ashley
Journal:  Arch Dermatol       Date:  2003-04

6.  The association of cigarette smoking with alveolar bone loss in postmenopausal females.

Authors:  J B Payne; R A Reinhardt; P V Nummikoski; D G Dunning; K D Patil
Journal:  J Clin Periodontol       Date:  2000-09       Impact factor: 8.728

7.  The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2006 Nov-Dec       Impact factor: 2.953

8.  Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis.

Authors:  Ann Cranney; Gordon Guyatt; Lauren Griffith; George Wells; Peter Tugwell; Clifford Rosen
Journal:  Endocr Rev       Date:  2002-08       Impact factor: 19.871

9.  Estrogen and/or calcium plus vitamin D increase mandibular bone mass.

Authors:  Charles F Hildebolt; Thomas K Pilgram; Mary Dotson; Reina Armamento-Villareal; Jay Hauser; Sheldon Cohen; Roberto Civitelli
Journal:  J Periodontol       Date:  2004-06       Impact factor: 6.993

10.  Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial.

Authors:  Philip M Preshaw; Arthur F Hefti; M John Novak; Bryan S Michalowicz; Bruce L Pihlstrom; Robert Schoor; Clarence L Trummel; John Dean; Thomas E Van Dyke; Clay B Walker; Mark H Bradshaw
Journal:  J Periodontol       Date:  2004-08       Impact factor: 6.993

View more
  18 in total

1.  Doxycycline effects on serum bone biomarkers in post-menopausal women.

Authors:  L M Golub; H-M Lee; J A Stoner; R A Reinhardt; T Sorsa; A D Goren; J B Payne
Journal:  J Dent Res       Date:  2010-03-26       Impact factor: 6.116

2.  Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases.

Authors:  David M Thompson; Hsi-Ming Lee; Julie A Stoner; Lorne M Golub; Pirkka V Nummikoski; Jeffrey B Payne
Journal:  J Periodontal Res       Date:  2019-04-29       Impact factor: 4.419

3.  The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial.

Authors:  Jeffrey B Payne; Lorne M Golub; Julie A Stoner; Hsi-Ming Lee; Richard A Reinhardt; Timo Sorsa; Marvin J Slepian
Journal:  J Am Dent Assoc       Date:  2011-03       Impact factor: 3.634

4.  Serum bone biomarkers and oral/systemic bone loss in humans.

Authors:  J B Payne; J A Stoner; H-M Lee; P V Nummikoski; R A Reinhardt; L M Golub
Journal:  J Dent Res       Date:  2011-03-21       Impact factor: 6.116

Review 5.  Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic.

Authors:  Jeffrey B Payne; Lorne M Golub
Journal:  Pharmacol Res       Date:  2010-10-16       Impact factor: 7.658

6.  Optimal combination of estimating equations in the analysis of multilevel nested correlated data.

Authors:  J A Stoner; B G Leroux; M Puumala
Journal:  Stat Med       Date:  2010-02-20       Impact factor: 2.373

Review 7.  Host-response therapeutics for periodontal diseases.

Authors:  William V Giannobile
Journal:  J Periodontol       Date:  2008-08       Impact factor: 6.993

8.  Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women.

Authors:  Lorne M Golub; Hsi Ming Lee; Julie A Stoner; Timo Sorsa; Richard A Reinhardt; Mark S Wolff; Maria E Ryan; Pirkka V Nummikoski; Jeffrey B Payne
Journal:  J Periodontol       Date:  2008-08       Impact factor: 6.993

9.  Alveolar bone measurement precision for phosphor-plate images.

Authors:  Charles F Hildebolt; Rex Couture; Nathalia M Garcia; Debra Dixon; D Doug Miley; William Shannon; Cheryl Mueller; Eric Langenwalter; Cathy Anderson Spearie; R Civitelli
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-09

10.  The association between clinical and radiographic periodontitis measurements during periodontal maintenance.

Authors:  Jeffrey B Payne; Pirkka V Nummikoski; David M Thompson; Lorne M Golub; Julie A Stoner
Journal:  J Periodontol       Date:  2012-12-03       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.